₹219.88
▼ 8.55%
Delayed · as of 17 Aug 2026
Dividend per share by financial year
| Financial year | Total dividend |
|---|---|
| FY11 | ₹0.75 |
| FY18 | ₹1.00 |
| FY20 | ₹1.00 |
| FY21 | ₹0.50 |
| FY22 | ₹1.00 |
| FY23 | ₹1.00 |
| FY24 | ₹1.00 |
| FY25 | ₹1.00 |
| FY26 | ₹1.00 |
Recent payouts
9 on record since FY11| Type | Amount | Ex-date | Record date | FY |
|---|---|---|---|---|
| FINAL | ₹1.00 | 19 Sep 2025 | ||
| FINAL | ₹1.00 | 19 Sep 2024 | ||
| FINAL | ₹1.00 | 20 Sep 2023 | ||
| FINAL | ₹1.00 | 19 Sep 2022 | ||
| FINAL | ₹1.00 | 16 Sep 2021 |
Against the marketIndex yields as of 17 Aug 2026+ Show– Hide
Index dividend yields are published by NSE alongside the closing levels. The dividend index is the fairer comparison: measured against the broad market almost every instrument here looks generous. A higher yield is not automatically better — it can mean a falling price as easily as a rising payout, which is what the chart above separates.
Yield through time
252 sessions · 07 Aug 2025 – 17 Aug 2026Trailing twelve-month payout divided by that session’s closing price, so a move here is either the payout changing or the price changing — the two readings a single current yield cannot tell apart. Ranged 0.24% to 0.45% over this window, ending at 0.45%. Closes and payouts are both split-adjusted, so a split does not appear as a change in yield. Tap or drag the chart to read a single session.
Others in Pharmaceuticals6 instruments+ Show– Hide
Ranked by published trailing-12-month yield. Classification is factual, not a recommendation.
Similar current yields
Same asset type, ordered by distance from this instrument’s published trailing-12-month yield. These are not business-sector peers or recommendations.